‘AIRA' an AI Co-Pilot for Health Workers in LMICs launched during the World Health Assembly 2025
Leveraging its strength in digital health innovation, Qure.ai has launched a new AI-powered co-pilot tool for frontline healthcare workers in resource-constrained geographies this week during the 78th World Health Assembly in Geneva.
'AIRA' is designed to optimize limited healthcare resources in Low- and Middle-Income Countries (LMICs) by supporting AI-enabled digitization of symptoms and patient history collection; clinical protocol adherence and decision support; and aggregated population health insights.
There are 17 million preventable deaths in LMICs and an estimated shortage of 11 million health workers by 20301. At the same time, more than 40% of community health workers' time is spent on manual data collection, and yet countries do not have population-level data to make informed decisions. AIRA aims to solve this urgent need by freeing up precious health worker time to engage more with patients, while digitizing data automatically.
Speaking at the World Health Assembly side-event on AI, Prashant Warier, CEO and Founder of Qure.ai, said, 'With AI, we can make a seismic shift towards health equity in LMICs. AIRA in the hands of every healthcare worker will free up their time for more patient interactions via automated data collection and better clinical protocol adherence. With AI, we can multiply every dollar spent and realize significantly more impact and returns in LMIC health systems. We have demonstrated this in our last 10 years in TB and are motivated to do the same now for primary healthcare.'
Dr. Michel Sidibé, Special Envoy at the African Union, said, 'Health ministries in developing nations need to deliver healthcare to their populations at a fraction of the budget compared to developed countries. We have to be creative to make this happen. Digital health and AI are most certainly catalysts to improve efficiency, access, and quality of care.'
AIRA is an AI co-pilot for healthcare workers in LMICs. It is built on Large Language Models (LLMs) with a deep understanding of Low- and Middle-Income Country health systems and needs. It is designed to reduce administrative workload and free up time for better patient care, while enabling better protocol adherence and population insights.
About Qure.ai
Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. Our solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Stroke to support clinicians and propel developments in the pharmaceutical and medical device industries. We empower healthcare by helping to identify conditions fast, prioritize treatment planning and ultimately improve quality of patient life.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
a day ago
- Zawya
IntelliDent AI and Manipal Academy of Higher Education sign strategic MoU to transform healthcare through AI
IntelliDent AI, a Dubai-based healthtech innovator transforming dentistry through artificial intelligence, has signed a Memorandum of Understanding (MoU) with the Manipal Academy of Higher Education (MAHE), India—an Institution of Eminence and global academic leader. This strategic three-year partnership aims to accelerate advancements in AI-powered oral healthcare through collaborative research, education, and entrepreneurship. The MoU, executed on behalf of MAHE's Manipal College of Dental Sciences (MCODS), Mangalore, lays the foundation for academic-industry cooperation focused on developing future-ready dental AI solutions and equipping students with the technical and entrepreneurial skills to lead the next era of digital healthcare. Key Pillars of the Collaboration: Joint Research Programs: MAHE and IntelliDent will co-develop research initiatives in AI-driven diagnostics, public health, and healthcare innovation—contributing to academic publications, patents, and whitepapers. Training & Internships: MAHE students will gain hands-on exposure through internships and mentorships at IntelliDent, supported by industry insights, guest lectures, and workshops. Entrepreneurial Development: The collaboration will foster cohort-based learning modules, innovation hackathons, and startup support to accelerate the commercialization of student-led healthtech ideas. Knowledge Exchange: Faculty, researchers, and industry experts will engage in reciprocal learning and cross-training to fuel innovation, skill-building, and strategic growth. Affaan Shaikh, Founder & CEO of IntelliDent AI, shared his thoughts on the collaboration: 'This partnership is about reimagining healthcare through ethical AI and innovation. We are thrilled to work alongside one of India's top institutions to shape the next generation of AI health leaders.' The MoU was signed by Dr. Giridhar P. Kini, Registrar of MAHE, and Mr. Affaan Shaikh, with active engagement from academic and innovation stakeholders from both organizations. This collaboration underscores IntelliDent AI's mission to scale accessible, AI-powered dental care globally and MAHE's continued commitment to integrating technology, research, and impact-driven education in the healthcare ecosystem. Together, MAHE and IntelliDent AI are building a bold future where education, innovation, and oral health equity intersect.
Zawya
3 days ago
- Zawya
The Department of Health – Abu Dhabi and Abbot unite to manufacture pharmaceuticals locally in Abu Dhabi
ABU DHABI, UAE /PRNewswire/ -- During BIO International Convention in Boston USA, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Abbott, the global healthcare leader, entered a landmark partnership to localise manufacturing of pharmaceuticals in Abu Dhabi and advance digital health solutions. Leveraging Abu Dhabi's advanced life sciences infrastructure, this milestone reflects the emirate's proactive preparedness to reduce dependency on imports, strengthen supply chain resilience, and foster a sustainable, self-sufficient healthcare ecosystem. H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: "Following the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi, the emirate proved to be equipped with a holistic, integrated infrastructure that fosters local manufacturing and R&D, positioning it as a regional healthcare gateway and leader in life sciences. By integrating our strategic vision with Abbott's expertise, we aim to accelerate the development and deployment of innovative healthcare products and solutions, reducing time-to-market, improving healthcare outcomes, and ensuring that breakthrough therapies reach patients faster. This approach positions Abu Dhabi as a regional leader in fostering an agile, innovation-driven healthcare ecosystem that directly translates scientific advancements into tangible benefits for our community." The strategic collaboration outlines a comprehensive plan focusing on four key pillars including localisation of Abbott's pharmaceutical portfolio, biosimilar development, digital transformation through electronic patient information leaflets, and a robust education and workforce development initiative. Mazen Bachir, Regional Director for Abbott's established pharmaceuticals business in the Gulf, Emerging Markets and Levant said: "Abbott is proud to announce a strategic collaboration with the Department of Health – Abu Dhabi, aimed at advancing healthcare resilience and innovation in Abu Dhabi. Building on Abbott's long-standing commitment to the UAE's healthcare system, this partnership will focus on localising existing pharmaceutical products, and jointly exploring the development of biosimilars, supported by regulatory alignment. The collaboration also includes initiatives to digitise life science product information through electronic leaflets in alignment with the UAE's digital health strategy. Another key component of this collaboration is the development of education programs to build local capabilities. Additionally, Abbott and the Department of Health will evaluate opportunities for joint research and development to strengthen long-term healthcare sustainability in the UAE." Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 15 to 21, 2025. The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, startAD and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI).
Tahawul Tech
4 days ago
- Tahawul Tech
drug discovery Archives
The synthetic data, which SandboxAQ is releasing publicly, can be used to train AI models that can predict whether a new drug molecule is likely to stick to the protein researchers are targeting.
